Filing Flows › Lifecore Biomedical (LFCR) › Q1 FY27
Lifecore Biomedical (LFCR) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Aug 5, 2026
Lifecore Biomedical (LFCR) reported revenue of $34.2M for the first quarter fiscal 2027 (Q1 FY27) and +47% from the quarter before. Operating margin was 7.5%, net loss $6.2M (18.0% of revenue).
Lifecore Biomedical, Q1 FY27: revenue $34.2M, operating margin 7.5%, net loss $6.2M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $34.2M | +47% | — |
| Operating profit | $2.6M | — | — |
| Net earnings | −$6.2M | — | — |
| Operating cash flow | −$2.2M | -147% | -224% |
What changed
Revenue was $34.2M in Q1 FY27, up 47% from the previous quarter. HA manufacturing was the largest line at 54% of revenue.
Gross margin was 35.3%. Operating profit was $2.6M, a 7.5% margin. The quarter ended with a net loss of $6.2M, narrower than the previous quarter's $15.0M loss. Net interest and other expense of $8.7M was the main reason.
Operating cash flow was −$2.2M. Non-cash charges added back $2.5M of depreciation and $2.1M of share-based compensation. Working capital and other items used $633K. Capital expenditures of $513K exceeded it, leaving free cash flow of −$2.7M.
Questions
What was Lifecore Biomedical's revenue in the first quarter fiscal 2027?
Lifecore Biomedical (LFCR) reported revenue of $34.2M for the first quarter fiscal 2027 (Q1 FY27) and +47% from the quarter before.
Was Lifecore Biomedical profitable in the first quarter fiscal 2027?
Operating profit was $2.6M (7.5% of revenue) and net loss $6.2M.